Literature DB >> 8260730

William L. McGuire Memorial Symposium. Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms.

G Freiss1, C Prébois, F Vignon.   

Abstract

Over the past two decades, the simple model for control of breast cancer growth involving one or two factors acting directly or indirectly via endocrine pathways has turned into a complex model implicating numerous interacting factors and the diverse cell populations constituting breast tumors. Current approaches to breast cancer therapy now require integration of these multiple parameters and enhanced understanding of the different levels of their intricate interactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260730     DOI: 10.1007/bf00683193

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  92 in total

Review 1.  Tyrosine-phosphorylated proteins: mediators of signal transduction from the tyrosine kinases.

Authors:  J R Glenney
Journal:  Biochim Biophys Acta       Date:  1992-03-16

2.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity.

Authors:  B J Mayer; P K Jackson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

3.  Antiestrogens antagonize the stimulatory effect of epidermal growth factor on the induction of progesterone receptor in fetal uterine cells in culture.

Authors:  C Sumida; J R Pasqualini
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

4.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

Authors:  P Masiakowski; R Breathnach; J Bloch; F Gannon; A Krust; P Chambon
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

5.  Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

Authors:  K B Horwitz; W L McGuire
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

6.  MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors.

Authors:  K B Horwitz; M E Costlow; W L McGuire
Journal:  Steroids       Date:  1975-12       Impact factor: 2.668

7.  Regulation of progesterone receptor-mediated transcription by phosphorylation.

Authors:  L A Denner; N L Weigel; B L Maxwell; W T Schrader; B W O'Malley
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

8.  Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin.

Authors:  R Poulin; J M Dufour; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

9.  Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.

Authors:  B A Arrick; M Korc; R Derynck
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

10.  Suramin binds to platelet-derived growth factor and inhibits its biological activity.

Authors:  M Hosang
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

View more
  3 in total

1.  Cadherins, steroids and cancer.

Authors:  O W Blaschuk; S B Munro; R Farookhi
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

2.  Functional IFNG polymorphism in intron 1 in association with an increased risk to promote sporadic breast cancer.

Authors:  Anjana Saha; Ashish Dhir; Anand Ranjan; Vibhuti Gupta; Narendra Bairwa; Ramesh Bamezai
Journal:  Immunogenetics       Date:  2005-03-09       Impact factor: 2.846

3.  The relationship of cytoplasmic intermediate filaments and membrane antigens with hormone receptors, nuclear staining density, and mode of stromal invasion in human breast cancer.

Authors:  C D Bell; E M Tischler; G J Laroye
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.